IP Verse

Biogaran patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Biogaran

Explore patent oppositions filed by Biogaran against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3345604
Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsH LUNDBECKMar 6, 2024
EP3578175
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 30, 2023
EP2653873
Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAApr 20, 2023
EP2959894
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISJan 13, 2023
EP2478907
Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJan 14, 2022
EP2234617
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 23, 2021
EP3395338
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 31, 2020
EP3260117
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENJan 17, 2020
EP3395339
Rapid Dissolution Formulation Of A Cinacalcet HclAMGENJan 17, 2020
EP3395340
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 17, 2020

Top competitors of Biogaran

Top competitors of Biogaran based on patent oppositions.